Document is current
Any future updates will be listed below
-
Authors
Ahmed, Nurilign https://orcid.org/0000-0003-3953-7473
Han, Ru https://orcid.org/0000-0002-4851-1462
Rodriguez, Edwin
Bibera, Gyneth Lourdes
Ortiz, Edgardo
Oladehin, Olakunle https://orcid.org/0000-0002-6151-1467
Gomez, Jorge A. https://orcid.org/0000-0001-5459-4973
-
Funding
Funding for this research was provided by:
GlaxoSmithKline Biologicals
- License Information
-
More Information
Article History
Received: 15 January 2024
Accepted: 29 April 2025
First Online: 2 June 2025
Declarations
:
: Nurilign Ahmed and Jorge Gomez are employed by and hold financial equities in GSK. Olakunle Oladehin and Gyneth Lourdes Bibera were employed by and held financial equities in GSK at the time of the study. Ru Han and Edwin Rodriguez are employed by GSK. Edgardo Ortiz is a part-time medical consultant for vaccines. These authors declare no other financial and non-financial relationships and activities and no conflicts of interest. Pneumosil is a trademark of Serum Institute of India. Synflorix is a trademark owned by or licensed to GSK. Prevenar 13 is a trademark of Pfizer.
: This analysis is based on previously conducted studies and does not contain any new studies with human participants or animals performed by any of the authors. Ethical approval for the development of the model was not required.
